Home » Stocks » Personalis

Personalis, Inc. (PSNL)

Stock Price: $25.70 USD 0.86 (3.46%)
Updated Oct 22, 2020 4:00 PM EDT - Market closed
After-hours: $25.50 -0.20 (-0.78%) Oct 22, 4:58 PM

Stock Price Chart

Key Info

Market Cap 988.51M
Revenue (ttm) 73.96M
Net Income (ttm) -31.92M
Shares Out 38.46M
EPS (ttm) -2.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 22, 2020
Last Price $25.70
Previous Close $24.84
Change ($) 0.86
Change (%) 3.46%
Day's Open 24.63
Day's Range 23.82 - 25.93
Day's Volume 538,160
52-Week Range 4.27 - 30.95

More Stats

Market Cap 988.51M
Enterprise Value 892.51M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 38.46M
Float 22.79M
EPS (basic) -0.84
EPS (diluted) -2.00
FCF / Share -1.19
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.63M
Short Ratio 2.52
Short % of Float 7.14%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 13.36
PB Ratio 11.50
Revenue 73.96M
Operating Income -32.05M
Net Income -31.92M
Free Cash Flow -37.67M
Net Cash 96.00M
Net Cash / Share 2.50
Gross Margin 29.85%
Operating Margin -43.33%
Profit Margin -43.20%
FCF Margin -50.93%
ROA -11.88%
ROE -30.38%
ROIC -58.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (8)

Buy 8
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(12.84% upside)
Current: $25.70
Target: 29.00
*Average 12-month price target from 7 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth72.62%302.15%-
Gross Profit22.0811.81-2.34
Operating Income-22.42-13.77-22.16
Net Income-25.08-19.89-23.60
Shares Outstanding18.013.063.03
Earnings Per Share-1.39-6.49-7.78
Operating Cash Flow-18.075.570.29
Capital Expenditures-8.38-7.85-5.16
Free Cash Flow-26.45-2.28-4.87
Cash & Equivalents12819.7422.62
Total Debt0.645.0017.51
Net Cash / Debt12814.755.11
Book Value107-106-92.60
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Personalis, Inc.
Country United States
Employees 181
CEO John S. West

Stock Information

Ticker Symbol PSNL
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: PSNL
IPO Date June 20, 2019


Personalis operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. Personalis, Inc. has partnership with Berry Genomics. The company was founded in 2011 and is headquartered in Menlo Park, California.